SelectQuote (SLQT) Faces Investor Lawsuit After DOJ Steps into Medicare Sales Probe – Hagens Berman
1. SelectQuote faces DOJ scrutiny over alleged deceptive sales practices. 2. A 19% drop in share price occurred due to DOJ’s intervention on May 1, 2025. 3. Class-action lawsuit filed for investors misled from Sept 2020 to May 2025. 4. Claims include misrepresentation of Medicare Advantage services and acceptance of kickbacks. 5. Shares have declined over 40% in six months due to legal and reputational concerns.